Trials / Completed
CompletedNCT00150293
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 337 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine long-term safety and efficacy of pregabalin in patients with partial seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin |
Timeline
- Start date
- 2002-03-01
- Completion
- 2005-11-01
- First posted
- 2005-09-08
- Last updated
- 2015-03-05
Locations
83 sites across 10 countries: Australia, Austria, Belgium, Canada, Germany, Netherlands, Poland, Portugal, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00150293. Inclusion in this directory is not an endorsement.